French Retail Investors Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®

Hosted by GenSight Biologics (EPA: SIGHT)
Date: Wednesday July 7th, 2021
Time: 8:30 - 9:30 am CEST

The event will be webcast live in French only at https://bit.ly/36fQ9yO.

GenSight’s management team will host a webcast on Wednesday July 7, 2021 from 8:30 am to 9:30 am CEST in French and dedicated to retail investors about the Topline results from REFLECT Phase III Clinical Trial of LUMEVOQ^® in the treatment of Leber Hereditary Optic Neuropathy (LHON) that GenSight reported on June 30, 2021..

Dr. José-Alain Sahel will attend and be available for questions.

Wednesday July 7, 2021

8:30 – 9:30 am CEST
The event will be webcast live in French at https://bit.ly/36fQ9yO

You will need to register in advance to get access to both webcasts. For those unable to attend the live broadcast, a recording will be accessible using the same links.